Japan — Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans

← back to leaderboard

Japan received 24 FDA import refusals in Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans between 2023-Q4 and 2026-Q3. Volume peaked at 4 in 2024-Q4, with the trend rising year-on-year. The most-cited issues are no english, suppl gmp, and dietarylbl. No trade baseline is published for this commodity from Japan, so no per-$1B rate is shown here.

Of these, 2 were hazard refusals and 22 were paperwork refusals.

Exporting from Japan? Get an email when shipments from Japan are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

2 2023-Q4 2023-Q4: 2 2 2024-Q1 2024-Q1: 2 1 2024-Q2 2024-Q2: 1 2 2024-Q3 2024-Q3: 2 4 2024-Q4 2024-Q4: 4 2 2025-Q1 2025-Q1: 2 0 2025-Q2 2025-Q2: 0 1 2025-Q3 2025-Q3: 1 4 2025-Q4 2025-Q4: 4 2 2026-Q1 2026-Q1: 2 3 2026-Q2 2026-Q2: 3 1 2026-Q3 2026-Q3: 1

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Supplements 17 no english
Herbals-Botanicals 8 suppl gmp

Recent rejections